Skip to content

Federal at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$7.51M-62.8%
Zymeworks logo
ZymeworksZYME
-$120.5K
Charles River Laboratories logo
Charles River LaboratoriesCRL
$2.72M-70.1%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.02B-54.5%

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:CurrentFederalTaxExpenseBenefit.

The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's federal.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's federal?
ADMA Biologics (ADMA) reported federal of $5.48M in Q4 2025.
How has ADMA Biologics's federal changed year-over-year?
ADMA Biologics's federal increased by 110.1% year-over-year, from $2.61M to $5.48M.
What does federal mean?
The total current tax expense or benefit recognized for federal income taxes based on the company's taxable income for the period. This reflects the immediate cash tax obligation or recovery owed to the national government. It is a critical component in understanding the company's overall effective tax burden.